It has been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart
transplant in December 1967 in South Africa. Remarkable progress has been made since …

Patients with advanced heart failure have a poor prognosis and heart transplant is still the
best treatment option. However, the scarcity of donors, long waiting times, and an increasing …

Abstract Purpose of Review The purpose of this review is to provide a comprehensive
update on recent advances in heart transplantation. Recent Findings Heart transplantation is …

BACKGROUND.: The lack of satisfactory donor organs limits heart transplantation. The
purpose of this study was to determine whether the criteria for suitability of donors may be …

Conference on cardiac transplantation in 2003 (1). The present Executive Summary
provides an update on the previous document, with a focus on new evidence and significant …

Heart transplantation remains the gold-standard therapy for end-stage heart failure; the
expected median survival range is 12–13 years. More than 30,000 heart transplants have …

Heart transplantation (HTx) has become standard treatment for selected patients with end-
stage heart failure. Improvements in immunosuppressant, donor procurement, surgical …

BACKGROUND: Cardiac retransplantation is considered to be the best therapeutic option
for a failing cardiac allograft. However, poor outcomes with retransplantation have …

The increased need for heart transplantation in patients with advanced heart failure has
introduced demand for a greater supply of donor hearts. Progress in cross-species …

Abstract Purpose of Review Despite the improvement in medical therapy for heart failure
and the advancements in mechanical circulatory support, heart transplantation (HT) still …